Literature DB >> 17680660

Degradation of paclitaxel and related compounds in aqueous solutions I: epimerization.

Jiaher Tian1, Valentino J Stella.   

Abstract

Paclitaxel and other taxanes have complex structures including the presence of numerous hydrolytically sensitive ester groups and a chiral center that readily undergoes epimerization thus making their kinetics complex. The present study attempts to understand the mechanism of epimerization at the 7-position of paclitaxel, 7-epi-taxol, 10-deacetyltaxol, 7-epi-10-deacetyltaxol, baccatin III and 10-deacetylbaccatin III. Kinetics were studied as function of temperature, pH and buffer concentration and analyzed using a stability indicating assay and LC/MS to identify degradation products. Epimerization was base catalyzed with no evidence of acid catalysis noted. The observed equilibrium constant for epimerization, K, indicated a thermodynamically more favorable S-epimer and a small free energy change between the two epimers. For all of the compounds in this study, removal of the C10 acetyl group increases the epimerization rate in basic aqueous solutions. The observed base-catalyzed epimerization in near neutral to higher pH range suggests a possible rapid deprotonation/protonation of the C7 -OH, followed by a structural rearrangement through a retroaldol/aldol mechanism to form the epimer. Moreover, the rate-limiting step of structure rearrangement most likely occurs with the formation of an enolate intermediate. (Copyright) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17680660     DOI: 10.1002/jps.21112

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Hydroxypropyl Beta Cyclodextrin as a Potential Surface Modifier for Paclitaxel Nanocrystals.

Authors:  Razan Haddad; Nasr Alrabadi; Bashar Altaani; Majed Masadeh; Tonglei Li
Journal:  AAPS PharmSciTech       Date:  2022-08-09       Impact factor: 4.026

2.  Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Authors:  Xiaowei Dong; Cynthia A Mattingly; Michael Tseng; Moo Cho; Val R Adams; Russell J Mumper
Journal:  Eur J Pharm Biopharm       Date:  2008-12-10       Impact factor: 5.571

3.  Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations.

Authors:  Valentino J Stella
Journal:  Pharm Res       Date:  2013-05-02       Impact factor: 4.200

4.  Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer.

Authors:  Kaat De Clercq; Feifan Xie; Olivier De Wever; Benedicte Descamps; Anne Hoorens; An Vermeulen; Wim Ceelen; Chris Vervaet
Journal:  Sci Rep       Date:  2019-10-16       Impact factor: 4.379

5.  HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer.

Authors:  Valentina Rapozzi; Francesca Moret; Luca Menilli; Andrea Guerrini; Daniele Tedesco; Marina Naldi; Manuela Bartolini; Mariachiara Gani; Sonia Zorzet; Marta Columbaro; Celeste Milani; Cecilia Martini; Claudia Ferroni; Greta Varchi
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.